NIH-funded research R01 grant

Using activity probes to improve microbiome therapies

Official title: Activity Probes to Guide Precision Microbiome Therapy

Funded at Weill Medical Coll of Cornell Univ · NIH-11180136 · Data updated 2026-11-12

This study is exploring how we can better understand and work with the tiny microbes in our bodies to improve health, especially for people dealing with obesity and cancer, by finding out which specific microbes can help us and creating personalized treatments just for them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$1,139,618
NIH project number5R01AT013241-02
Project IDNIH-11180136 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from obesity, cancer, or inflammatory diseases related to microbiome imbalances.

Less likely to help

Patients with stable microbiome profiles or those not affected by the conditions being studied may not benefit from this research.

What this research studies

This research investigates how to better understand and manipulate the human microbiome, which is crucial for health and disease management, particularly in conditions like obesity and cancer. By employing innovative activity-based probes, the study aims to directly measure the functions of microbial proteins, rather than relying on indirect indicators. This approach will help identify specific microbial taxa with beneficial functions, paving the way for tailored microbiome therapies that can be tested in clinical settings. Patients may benefit from more effective treatments that target their unique microbiome profiles.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized microbiome-based therapies for various health conditions.

How similar studies have gone: Other research has shown promise in using microbiome profiling for therapeutic purposes, but this approach using activity-based probes is relatively novel.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Longman, Randy S — Weill Medical Coll of Cornell Univ
  • Study coordinator: Longman, Randy S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.